About this trial
To determine if sucralose, an artificial sweetener, modulates nicotine threshold doses for discrimination, subjective-rewarding effects, and reinforcement in smokers with varying levels of dependence.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Smoking at least for one year and more frequently than once a week, smoking status confirmed with a semi-quantitative urine nicotine test. Smokers will be stratified by level of dependence, assessed with the FTND 29 low or no dependence ≤3 and moderate or high dependence ≥ 4.
In good health as verified by medical history, screening examination, and screening laboratory tests.
For women, report using acceptable birth control methods.
Disqualifiers
History of major medical or psychiatric disorders that the physician investigator deems as contraindicated for the participant to be in the study;
regular current use of certain psychotropic medications (such as mood stabilizers, antipsychotics, or anxiolytics being prescribed to treat bipolar disorder, psychosis or anxiety spectrum disorders, respectively);
current untreated alcohol or substance use disorder for any other recreational or prescription drugs other than nicotine;
for women, pregnant as determined by pregnancy screening, or breastfeeding; and 5) seeking (or undergoing) treatment for tobacco dependence or smoking.
Trial design
Crossover
Treatments tested in this trial
Nicotine 0.05 mg/pulse and 0.1 mg/pulse
DrugNicotine will be used and compared to saline given by IV push by study physician
Saline Placebo (0.5mL injection)
DrugSaline will be used compared to the low dose of Nicotine given by IV push by study physician
sucralose
Dietary supplementsweet flavor (sucralose) compared to unsweetened flavor
Sugar syrup (Placebo)
Dietary supplementUnsweetened flavor compared to the sweetened flavor sucralose.
Treatment groups
Trial outcomes
Primary outcomes
Drug Discrimination Scale (DDS) score.
This scale asks the participants to select if they received Drug A or B and how confident they are in their selection on a scale of 0 to 10. Higher scores indicate more confidence.
Drug Effects Questionnaire (DEQ) pleasurable effects score
The DEQ pleasurable effects consists of 11 questions with total score range from 0-100. Higher scores indicate more positive effects.
Secondary outcomes
Minnesota Nicotine Withdrawal Scale score
This 8-item scale will be used to assess DSM-IV symptoms of nicotine withdrawal. Total score range 0-32. Higher scores indicate more severe withdrawal symptoms.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Yale University
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: